Stockreport

Ocular Therapeutix, Inc. (OCUL) Discusses Phase III SOL-1 Data Highlighting Transformative Durability in Wet AMD Transcript [Seeking Alpha]

Ocular Therapeutix, Inc.  (OCUL) 
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ocutx.com
PDF Company Participants William Slattery - Vice President of Investor Relations Pravin Dugel - Executive Chairman, President & CEO Peter Kaiser - Chief Development O [Read more]